Explore our sister journals here.

Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Citing this Article

Right click to copy or hit: ctrl+c (cmd+c on mac)

Published on 15.12.16 in Vol 2, No 2 (2016): Jul-Dec

This paper is in the following e-collection/theme issue:

Works citing "Clinical Trial Electronic Portals for Expedited Safety Reporting: Recommendations from the Clinical Trials Transformation Initiative Investigational New Drug Safety Advancement Project"

Raymond P Perez, Shanda Finnigan, Krupa Patel, Shanell Whitney, Annemarie Forrest

JMIR Cancer 2016 (Dec 15); 2(2):e16 

According to Crossref, the following articles are citing this article (DOI 10.2196/cancer.6701):

(note that this is only a small subset of citations)

  1. Levit LA, Perez RP, Smith DC, Schilsky RL, Hayes DF, Vose JM. Streamlining Adverse Events Reporting in Oncology: An American Society of Clinical Oncology Research Statement. Journal of Clinical Oncology 2018;36(6):617
    CrossRef
  2. Corneli A, Hallinan Z, Hamre G, Perry B, Goldsack JC, Calvert SB, Forrest A. The Clinical Trials Transformation Initiative: Methodology supporting the mission. Clinical Trials 2018;15(1_suppl):13
    CrossRef
  3. Park YR, Koo H, Yoon Y, Park S, Lim Y, Baek S, Kim HR, Kim TW. Expedited Safety Reporting to Sponsors Through the Implementation of an Alert System for Clinical Trial Management at an Academic Medical Center: Retrospective Design Study. JMIR Medical Informatics 2020;8(2):e14379
    CrossRef
  4. Riordan DO, Kinane M, Walsh KA, Shiely F, Eustace J, Bermingham M. Stakeholders’ knowledge, attitudes and practices to pharmacovigilance and adverse drug reaction reporting in clinical trials: a mixed methods study. European Journal of Clinical Pharmacology 2020;76(10):1363
    CrossRef
  5. Margas W, Wojciechowski P, Toumi M. Impact of the COVID-19 pandemic on the conduct of clinical trials: a quantitative analysis. Journal of Market Access & Health Policy 2022;10(1)
    CrossRef
  6. Boutzoukas AE, Olson R, Sellers MA, Fischer G, Hornik CD, Alibrahim O, Iheagwara K, Abulebda K, Bass AL, Irby K, Subbaswamy A, Zivick EE, Sweney J, Stormorken AG, Barker EE, Lutfi R, McCrory MC, Costello JM, Ackerman KG, Munoz Pareja JC, Dean JM, Abdelsamad N, Hanley DF, Mould WA, Lane K, Stroud M, Feger BJ, Greenberg RG, Smith PB, Benjamin DK, Hornik CP, Zimmerman KO, Becker ML. Mechanisms to expedite pediatric clinical trial site activation: The DOSE trial experience. Contemporary Clinical Trials 2023;125:107067
    CrossRef